Valeo Financial Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Valeo Financial Advisors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-50	Closed	–	–	1729
2019 Q1	$0	Hold	50	–	–	﹤0.01%	1692
2018 Q4	$0	Hold	50	–	–	﹤0.01%	1894
2018 Q3	$0	Hold	50	–	–	﹤0.01%	1942
2018 Q2	$0	Hold	50	–	–	﹤0.01%	1841
2018 Q1	$0	Buy	+50	New	+$138	﹤0.01%	1659

Valeo Financial Advisors's OMED Position: Q2 2019 in Review

Valeo Financial Advisors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 50 shares.

Valeo Financial Advisors first reported a position in OMED in Q1 2018 and held it in 5 quarters. The position peaked at $0 in Q1 2019. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Valeo Financial Advisors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Valeo Financial Advisors sold 50 OncoMed Pharmaceuticals, Inc. shares in Q2 2019.
Valeo Financial Advisors first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2018 and held it in 5 quarters.
Valeo Financial Advisors's OncoMed Pharmaceuticals, Inc. position peaked at $0 in Q1 2019.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Valeo Financial Advisors's 13F filing for Q2 2019, filed 10 Jul 2019.